United States Drug of Abuse Testing Market Report 2017

November 2017 | 100 pages | ID: U64C9C85959WEN
QYResearch

Abstracts

In this report, the United States Drug of Abuse Testing market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest

with sales (volume), revenue (value), market share and growth rate of Drug of Abuse Testing in these regions, from 2012 to 2022 (forecast).
United States Drug of Abuse Testing market competition by top manufacturers/players, with Drug of Abuse Testing sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Roche Holding Limited
• Quest Diagnostics
• Laboratory Corporation of America Holdings
• Alere Inc
• Abbott Laboratories
• Randox Laboratories
• Psychemedics Corporation
• Bio-Rad Laboratories
• Sonic Healthcare
• Thermo Fisher Scientific Inc

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Onsite Screening Test
• Laboratory Drug Testing

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Drug of Abuse Testing for each application, including

• Urine
• Hair
• Saliva

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Drug of Abuse Testing Market Report 2017

1 DRUG OF ABUSE TESTING OVERVIEW

1.1 Product Overview and Scope of Drug of Abuse Testing
1.2 Classification of Drug of Abuse Testing by Product Category
  1.2.1 United States Drug of Abuse Testing Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Drug of Abuse Testing Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Onsite Screening Test
  1.2.4 Laboratory Drug Testing
1.3 United States Drug of Abuse Testing Market by Application/End Users
  1.3.1 United States Drug of Abuse Testing Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Urine
  1.3.3 Hair
  1.3.4 Saliva
1.4 United States Drug of Abuse Testing Market by Region
  1.4.1 United States Drug of Abuse Testing Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Drug of Abuse Testing Status and Prospect (2012-2022)
  1.4.3 Southwest Drug of Abuse Testing Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Drug of Abuse Testing Status and Prospect (2012-2022)
  1.4.5 New England Drug of Abuse Testing Status and Prospect (2012-2022)
  1.4.6 The South Drug of Abuse Testing Status and Prospect (2012-2022)
  1.4.7 The Midwest Drug of Abuse Testing Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Drug of Abuse Testing (2012-2022)
  1.5.1 United States Drug of Abuse Testing Sales and Growth Rate (2012-2022)
  1.5.2 United States Drug of Abuse Testing Revenue and Growth Rate (2012-2022)

2 UNITED STATES DRUG OF ABUSE TESTING MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Drug of Abuse Testing Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Drug of Abuse Testing Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Drug of Abuse Testing Average Price by Players/Suppliers (2012-2017)
2.4 United States Drug of Abuse Testing Market Competitive Situation and Trends
  2.4.1 United States Drug of Abuse Testing Market Concentration Rate
  2.4.2 United States Drug of Abuse Testing Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Drug of Abuse Testing Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES DRUG OF ABUSE TESTING SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Drug of Abuse Testing Sales and Market Share by Region (2012-2017)
3.2 United States Drug of Abuse Testing Revenue and Market Share by Region (2012-2017)
3.3 United States Drug of Abuse Testing Price by Region (2012-2017)

4 UNITED STATES DRUG OF ABUSE TESTING SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Drug of Abuse Testing Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Drug of Abuse Testing Revenue and Market Share by Type (2012-2017)
4.3 United States Drug of Abuse Testing Price by Type (2012-2017)
4.4 United States Drug of Abuse Testing Sales Growth Rate by Type (2012-2017)

5 UNITED STATES DRUG OF ABUSE TESTING SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Drug of Abuse Testing Sales and Market Share by Application (2012-2017)
5.2 United States Drug of Abuse Testing Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES DRUG OF ABUSE TESTING PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Roche Holding Limited
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Drug of Abuse Testing Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Roche Holding Limited Drug of Abuse Testing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Quest Diagnostics
  6.2.2 Drug of Abuse Testing Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Quest Diagnostics Drug of Abuse Testing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Laboratory Corporation of America Holdings
  6.3.2 Drug of Abuse Testing Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Laboratory Corporation of America Holdings Drug of Abuse Testing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Alere Inc
  6.4.2 Drug of Abuse Testing Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Alere Inc Drug of Abuse Testing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Abbott Laboratories
  6.5.2 Drug of Abuse Testing Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Abbott Laboratories Drug of Abuse Testing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Randox Laboratories
  6.6.2 Drug of Abuse Testing Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Randox Laboratories Drug of Abuse Testing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Psychemedics Corporation
  6.7.2 Drug of Abuse Testing Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Psychemedics Corporation Drug of Abuse Testing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Bio-Rad Laboratories
  6.8.2 Drug of Abuse Testing Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Bio-Rad Laboratories Drug of Abuse Testing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Sonic Healthcare
  6.9.2 Drug of Abuse Testing Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Sonic Healthcare Drug of Abuse Testing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Thermo Fisher Scientific Inc
  6.10.2 Drug of Abuse Testing Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Thermo Fisher Scientific Inc Drug of Abuse Testing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 DRUG OF ABUSE TESTING MANUFACTURING COST ANALYSIS

7.1 Drug of Abuse Testing Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Drug of Abuse Testing

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Drug of Abuse Testing Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Drug of Abuse Testing Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Drug of Abuse Testing Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Drug of Abuse Testing Sales Volume Forecast by Type (2017-2022)
11.3 United States Drug of Abuse Testing Sales Volume Forecast by Application (2017-2022)
11.4 United States Drug of Abuse Testing Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Drug of Abuse Testing
Figure United States Drug of Abuse Testing Market Size (K Pcs) by Type (2012-2022)
Figure United States Drug of Abuse Testing Sales Volume Market Share by Type (Product Category) in 2016
Figure Onsite Screening Test Product Picture
Figure Laboratory Drug Testing Product Picture
Figure United States Drug of Abuse Testing Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Drug of Abuse Testing by Application in 2016
Figure Urine Examples
Table Key Downstream Customer in Urine
Figure Hair Examples
Table Key Downstream Customer in Hair
Figure Saliva Examples
Table Key Downstream Customer in Saliva
Figure United States Drug of Abuse Testing Market Size (Million USD) by Region (2012-2022)
Figure The West Drug of Abuse Testing Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Drug of Abuse Testing Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Drug of Abuse Testing Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Drug of Abuse Testing Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Drug of Abuse Testing Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Drug of Abuse Testing Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Drug of Abuse Testing Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Drug of Abuse Testing Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Drug of Abuse Testing Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Drug of Abuse Testing Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Drug of Abuse Testing Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Drug of Abuse Testing Sales Share by Players/Suppliers
Figure 2017 United States Drug of Abuse Testing Sales Share by Players/Suppliers
Figure United States Drug of Abuse Testing Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Drug of Abuse Testing Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Drug of Abuse Testing Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Drug of Abuse Testing Revenue Share by Players/Suppliers
Figure 2017 United States Drug of Abuse Testing Revenue Share by Players/Suppliers
Table United States Market Drug of Abuse Testing Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Drug of Abuse Testing Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Drug of Abuse Testing Market Share of Top 3 Players/Suppliers
Figure United States Drug of Abuse Testing Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Drug of Abuse Testing Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Drug of Abuse Testing Product Category
Table United States Drug of Abuse Testing Sales (K Pcs) by Region (2012-2017)
Table United States Drug of Abuse Testing Sales Share by Region (2012-2017)
Figure United States Drug of Abuse Testing Sales Share by Region (2012-2017)
Figure United States Drug of Abuse Testing Sales Market Share by Region in 2016
Table United States Drug of Abuse Testing Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Drug of Abuse Testing Revenue Share by Region (2012-2017)
Figure United States Drug of Abuse Testing Revenue Market Share by Region (2012-2017)
Figure United States Drug of Abuse Testing Revenue Market Share by Region in 2016
Table United States Drug of Abuse Testing Price (USD/Pcs) by Region (2012-2017)
Table United States Drug of Abuse Testing Sales (K Pcs) by Type (2012-2017)
Table United States Drug of Abuse Testing Sales Share by Type (2012-2017)
Figure United States Drug of Abuse Testing Sales Share by Type (2012-2017)
Figure United States Drug of Abuse Testing Sales Market Share by Type in 2016
Table United States Drug of Abuse Testing Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Drug of Abuse Testing Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Drug of Abuse Testing by Type (2012-2017)
Figure Revenue Market Share of Drug of Abuse Testing by Type in 2016
Table United States Drug of Abuse Testing Price (USD/Pcs) by Types (2012-2017)
Figure United States Drug of Abuse Testing Sales Growth Rate by Type (2012-2017)
Table United States Drug of Abuse Testing Sales (K Pcs) by Application (2012-2017)
Table United States Drug of Abuse Testing Sales Market Share by Application (2012-2017)
Figure United States Drug of Abuse Testing Sales Market Share by Application (2012-2017)
Figure United States Drug of Abuse Testing Sales Market Share by Application in 2016
Table United States Drug of Abuse Testing Sales Growth Rate by Application (2012-2017)
Figure United States Drug of Abuse Testing Sales Growth Rate by Application (2012-2017)
Table Roche Holding Limited Basic Information List
Table Roche Holding Limited Drug of Abuse Testing Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Roche Holding Limited Drug of Abuse Testing Sales Growth Rate (2012-2017)
Figure Roche Holding Limited Drug of Abuse Testing Sales Market Share in United States (2012-2017)
Figure Roche Holding Limited Drug of Abuse Testing Revenue Market Share in United States (2012-2017)
Table Quest Diagnostics Basic Information List
Table Quest Diagnostics Drug of Abuse Testing Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Quest Diagnostics Drug of Abuse Testing Sales Growth Rate (2012-2017)
Figure Quest Diagnostics Drug of Abuse Testing Sales Market Share in United States (2012-2017)
Figure Quest Diagnostics Drug of Abuse Testing Revenue Market Share in United States (2012-2017)
Table Laboratory Corporation of America Holdings Basic Information List
Table Laboratory Corporation of America Holdings Drug of Abuse Testing Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Laboratory Corporation of America Holdings Drug of Abuse Testing Sales Growth Rate (2012-2017)
Figure Laboratory Corporation of America Holdings Drug of Abuse Testing Sales Market Share in United States (2012-2017)
Figure Laboratory Corporation of America Holdings Drug of Abuse Testing Revenue Market Share in United States (2012-2017)
Table Alere Inc Basic Information List
Table Alere Inc Drug of Abuse Testing Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Alere Inc Drug of Abuse Testing Sales Growth Rate (2012-2017)
Figure Alere Inc Drug of Abuse Testing Sales Market Share in United States (2012-2017)
Figure Alere Inc Drug of Abuse Testing Revenue Market Share in United States (2012-2017)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Drug of Abuse Testing Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Abbott Laboratories Drug of Abuse Testing Sales Growth Rate (2012-2017)
Figure Abbott Laboratories Drug of Abuse Testing Sales Market Share in United States (2012-2017)
Figure Abbott Laboratories Drug of Abuse Testing Revenue Market Share in United States (2012-2017)
Table Randox Laboratories Basic Information List
Table Randox Laboratories Drug of Abuse Testing Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Randox Laboratories Drug of Abuse Testing Sales Growth Rate (2012-2017)
Figure Randox Laboratories Drug of Abuse Testing Sales Market Share in United States (2012-2017)
Figure Randox Laboratories Drug of Abuse Testing Revenue Market Share in United States (2012-2017)
Table Psychemedics Corporation Basic Information List
Table Psychemedics Corporation Drug of Abuse Testing Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Psychemedics Corporation Drug of Abuse Testing Sales Growth Rate (2012-2017)
Figure Psychemedics Corporation Drug of Abuse Testing Sales Market Share in United States (2012-2017)
Figure Psychemedics Corporation Drug of Abuse Testing Revenue Market Share in United States (2012-2017)
Table Bio-Rad Laboratories Basic Information List
Table Bio-Rad Laboratories Drug of Abuse Testing Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bio-Rad Laboratories Drug of Abuse Testing Sales Growth Rate (2012-2017)
Figure Bio-Rad Laboratories Drug of Abuse Testing Sales Market Share in United States (2012-2017)
Figure Bio-Rad Laboratories Drug of Abuse Testing Revenue Market Share in United States (2012-2017)
Table Sonic Healthcare Basic Information List
Table Sonic Healthcare Drug of Abuse Testing Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sonic Healthcare Drug of Abuse Testing Sales Growth Rate (2012-2017)
Figure Sonic Healthcare Drug of Abuse Testing Sales Market Share in United States (2012-2017)
Figure Sonic Healthcare Drug of Abuse Testing Revenue Market Share in United States (2012-2017)
Table Thermo Fisher Scientific Inc Basic Information List
Table Thermo Fisher Scientific Inc Drug of Abuse Testing Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Thermo Fisher Scientific Inc Drug of Abuse Testing Sales Growth Rate (2012-2017)
Figure Thermo Fisher Scientific Inc Drug of Abuse Testing Sales Market Share in United States (2012-2017)
Figure Thermo Fisher Scientific Inc Drug of Abuse Testing Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Drug of Abuse Testing
Figure Manufacturing Process Analysis of Drug of Abuse Testing
Figure Drug of Abuse Testing Industrial Chain Analysis
Table Raw Materials Sources of Drug of Abuse Testing Major Players/Suppliers in 2016
Table Major Buyers of Drug of Abuse Testing
Table Distributors/Traders List
Figure United States Drug of Abuse Testing Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Drug of Abuse Testing Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Drug of Abuse Testing Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Drug of Abuse Testing Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Drug of Abuse Testing Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Drug of Abuse Testing Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Drug of Abuse Testing Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Drug of Abuse Testing Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Drug of Abuse Testing Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Drug of Abuse Testing Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Drug of Abuse Testing Sales Volume Share Forecast by Region (2017-2022)
Figure United States Drug of Abuse Testing Sales Volume Share Forecast by Region (2017-2022)
Figure United States Drug of Abuse Testing Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources